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Aims: To assess the endothelial function of the skin
microcirculation in chronic renal failure (CRF) indepen-
dent of hypertension,we investigatedthe changes of the
cutaneous blood flow induced by iontophoretic delivery
of acetylcholine (ACh) and of sodium nitroprusside
(SNP) in CRF patientsfree from arterialhypertensionand
in patients with essential hypertension. Methods:The
studyincluded20patientsaffectedby CRF (meancreati-
nine clearance 12 :t 2 mlfmin)without arterialhyperten-
sion (mean blood pressure 96 :t 1 mm Hg), 15 patients
affectedby essential hypertension (meanblood pressure
124:t 1 mm Hg),and 20 normal controls.Thechangesof
skin blood flow following iontophoretic delivery of ACh
and of SNP were measured by laser Doppler flowmetry.
Results:FollowingmaximalACh or SNP delivery, the
change of blood flow from the baselinewas similar both
innormals(683:t 92vs. 684 :t 87%) and in CRF patients
(778 :t 108vs. 803 :t 124%),whereas in the hyperten-







sivestheresponsetoAChwas lowerthanto SNP (434 :t
48vs. 702 :t 98%, p <0.01).Since the third AChdelivery
dose,the skin blood flow increments were significantly
lower in the hypertensive than in the CRF or in the nor-
mal control groups, whereas no differencewas observed
between uremics and controls. Conclusions:The endo-
thelium-dependent hyperemiafollowing ACh iontophor-
etic delivery is impaired in the skin microcirculation of
essential hypertensivepatients,but this is notthe case in
CRF patients with no historyof arterialhypertension.


















impairedin adultdialysispatientsand in childrenwith
chronicrenalfailure(CRF) [4-6].On thecontrary,exper-
imentaldatafailed to demonstratesimilar findingsin
mesentericarteriesof uremicrats[7].Moreover,up to
date,endothelium-dependentvasodilationofsmallarteri-




the forearm[8-11]. Since it is welI known that CRF
patientsareusualIyhypertensive,thequestionarisesas






The recentuse of iontophoresiscoupledwith laser
Doppler flowmetry[12] alIowsto assessthe real-time






changesof cutaneousblood flow inducedby the ionto-
phoreticdeliveryof an endothelium-dependent(acetyl-
choline;ACh) andof anendothelium-independent(sodi-





















































Age,years 45:t3 49:t2 44:t3
Cholesterol,mg/di 183:tlO 188:t4 174:t3
Triglycerides,mg/dl 177:t18 96:t14 87:t6
Fasting lucose,mg/dl 91:t2 92:tl 90:tI
Creatinine,mg/dl 6.5:t0.5** 0.8:t0.0 0.8:t0.0
Bloodureanitrogen,mg/dl 49:t5** 13:t1 14:t1
Calcium,mg/dl 8.9:t0.1* 9.4:t0.1 9.3:t0.1
Phosphate,mg/dl 4.2:t0.2* 3.7:t0.1 3.8:t0.1
Potassium,mEq/1 4.4:t0.1* 4.0:t0.1 3.8:t0.1
Sodium,mEq/1 140:tl 141:t1 140:tl
Hematocrit,% 31.5:t 1.2** 40:tl 39:tl
Totalproteins,g/dl 7.0:t0.2 6.9:t0.1 7.1:t0.1
Albumin,gldi 4.0:t0.1 4.0:t0.1 4.1:t0.1
Bloodpressure,mmHg
Systolic 131:t3 172:t300 134:t4
Diastolic 78:t1 100:t200 78:t2
Mean 96:tl 124:t1o0 97:t2
*p<0.01,**p<0.001vs.EHT andvs.NC groups.















Fig. 1. Percentagechangefrom baselineof themaximalskin blood
flow followingACh or SNP iontophoreticdeliveryin theNC (open
columns), EHT (hatchedcolumns); and CRF (dotted columns)
groups.*p <0.05vs.NC andCRF groups.
Procedures
Endothelium-dependentor endothelium-independenthyperemia
was determinedby the combination of iontophoresisand laser
Doppler flowmetry.
Skin erythrocyteflow measurementswerecarriedout in a tem-
perature-controlledroom(22 :t 1oC), with the subjectslying in
supineposition,aftera 20-minacc1imatizationperiodoBeforestart-
ing,theskinofthe forearmwascarefullyc1eanedusinga1cohol.
Iontophoresishas been used to deliver vasoactivesubstances
acrossthe skin of the forearm,avoiding the systemiceffectsthat
couldinterferewith theskinmicrocirculatoryresponses.In fact,this
method allows to locally transferchargeddrugs acrossthe skin
throughasmallelectriccurrent[17].The currentstrengthschosenfor
ourstudywerewelltoleratedby themajorityofthe subjects,whereas
a mild pricklingsensationwasreportedin a fewcases.We havepre-
viously evaluatedthe effectof iontophoresiscurrent itselfon skin
blood flow: negligiblechangeswereinducedby the sameduration
and strengthof theelectriccurrentwe usedin thepresentstudy.A
drugdeliveryelectrode(PF 383;Perimed,Jarfàlla,Sweden)andan




Before to be attachedon the skin, the drug deliveryelectrode
chamberwasfilledwith 62.5Jll of 1%ACh solutionandwith 62.5Jll
of 1% SNP solution. A battery-powerediontophoresiscontroller
(Perilout328,PowerSupply)wasusedtoprovidethecurrentfor drug
administration.After registrationof the baselineflow,ACh was
deliveredusingan anodalcurrent:six doses(0.1mA for 20 s each)
followedbyanothertwodoses(0.2mAfor20sand0.3mAfor20s)
weredeliveredwitha 60-secondintervalbetweeneachsingledose.
The 60-secondinterval was neededto achievethe plateauof the
hyperemiainducedbyeachACh delivery.
After a 1-minrecoveryperiod,SNP wasdeliveredusinga catho-
dalcurrent:two doses(0.1mA for 20 s each)followedby one dose




BeforeandduringACh or SNP delivery,theskinerythrocyteflow
wasmeasuredby meansof a laser Doppler flowmeter(Periflux
PF4001, standardprobePF408, Perimed).The laserDoppler probe
wasfixedwithin thedrugchamberto explorethesamesmallareaof














in stableemulsionwithan intra-assaycoefficientof variationof
about6%[20].Inhumans,thetechniqueshowsacoefficientofvaria-
tionof20-21%[21].
In orderto eliminatebaselinevariability,thebloodflow re-
sponsestoAChandSNPdeliverieswereexpressedaspercentchange
fromthebaseline[12,22].Similarly,theflowincrementfollowing
eachone of theeightiontophoreticallyappliedACh doseswas
expressedaspercentageof themaximalendothelium-independent
responseto SNP as follows:100.ACh-inducedflow/maxSNP-
inducedflow.
Statistics








responseto ACh, whereasno differencebetweengroups
hasbeenobservedasfar as theresponsesto SNP were
concerned.To confirm,in theCRF group,theabsolute
incrementfrombaselinetomaximalflowfollowingACh
deliverywas similarto that obtainedby SNP delivery
(30.8 :t 3.0vs. 32.6 :t 4.2PU, respectively;n.s.),as it
occurredin theNC group(25.7:t 5.6vs.25.9:t 5.4PU,
n.s.).On theotherhand,in theEHT group,themaximal
ACh-inducedincrementof blood flow wassignificantly
lowerthanthatobtainedby SNP (20.7:t 2.3vs.39.1:t
6.3 PU; p < 0.01).AlthoughCRF patientshad lower
hematocritvalues(table1),theyshowedskinbloodflow






























eticdeliveryof ACh wasfollowedby aprogressiveincre-
mentofcutaneousbloodflowin thethreestudiedgroups.
However,in theEHT groupthebloodflowchangeswere














lation of vasculartone by releasingvasodilatingsub-
stancesuchasnitricoxide(NO) anddilatorprostanoids,
andcontractingonessuchasconstrictorprostanoidsand









































lium-dependenthyperemicresponseto ACh is notim-
pairedin theskinof chronicrenalfailurepatientsfree
fromahistoryofarterialhypertension.



















































phoreticdeliveryof ACh andSNP. Iontophoresisi a
techniquecommonlyusedtoallowthelocalabsorption
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